Vialwirebiotech, curated
July 22, 2026, 12:38 AM
June 29, 2026
- 11:00 PM · SCMP — Tech
- 4:17 PM · STAT News
- 12:51 PM · STAT News12:51 PMSTAT+: Longevity, wellness physicians named to panel advising FDA on peptides — STAT News
- 12:00 PM · BioWorld12:00 PMEMA reverses its stance on Acadia’s Rett syndrome therapy Daybu — BioWorld
- 12:00 PM · BioWorld12:00 PMSamsung Bioepis’ Keytruda biosimilar hits phase I, III endpoints — BioWorld
- 12:00 PM · BioWorld12:00 PMRoche launches Axelios 1 sequencing platform to rival Illumina — BioWorld
- 9:00 AM · BioWorld9:00 AMGensci-144 shows renoprotection in CKD — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMOnco-Innovations evaluates ONC-010 in metabolism studies — BioWorld
- 6:42 AM · Pharmaceutical Technology6:42 AMBiogen trims Apellis pipeline and R&D team after $5.6bn takeover — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMFDA clears base editing therapy for phenylketonuria — Drug Discovery World
- 5:07 AM · Pharmaceutical Technology5:07 AMFDA issues complete response letter to Sobi’s NASP for gout — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMPheno Therapeutics heads towards human testing of MS therapy — Drug Discovery World
- 3:05 AM · Pharmaceutical Technology3:05 AMLilly’s Jaypirca receives CHMP positive opinion for CLL in Europe — Pharmaceutical Technology
- 12:30 AM · STAT News
June 28, 2026
- 11:00 PM · SCMP — Tech11:00 PMChina’s first AI-powered cancer vaccine production line set to launch in Beijing — SCMP — Tech